Related Experiment Videos
Endoscopic holmium:YAG laser dacryocystorhinostomy
S A Sadiq1, C E Hugkulstone, N S Jones
1Department of Ophthalmology, University Hospital, Nottingham, UK.
Eye (London, England)
|January 1, 1996
Summary
The holmium:YAG laser technique for endonasal laser dacryocystorhinostomy achieved a 70% success rate in relieving nasolacrimal obstruction. This minimally invasive approach offers a quicker, outpatient alternative to conventional surgery.
Area of Science:
- Ophthalmology
- Otolaryngology
- Laser Surgery
Background:
- Nasolacrimal duct obstruction causes significant discomfort and visual impairment.
- Conventional dacryocystorhinostomy (DCR) is an established surgical treatment.
- Endonasal laser techniques offer potential advantages in minimally invasive surgery.
Purpose of the Study:
- To present early results of primary endonasal laser dacryocystorhinostomy (ELDC) using the holmium:YAG laser.
- To evaluate the efficacy and patient acceptance of ELDC compared to conventional DCR.
Main Methods:
- Retrospective analysis of 50 primary endonasal laser dacryocystorhinostomies in 49 patients using holmium:YAG laser.
- Comparison with a retrospective study of 67 patients undergoing conventional DCR.
- Data collection included success rates, follow-up duration, anesthesia type, inpatient/outpatient status, surgery time, and patient satisfaction.
Main Results:
- Overall success rate for ELDC was 70% (35/50 patients) after a 4-month follow-up.
- Success rate improved to 79% in patients with nasolacrimal intubation.
- ELDC procedures were significantly quicker, performed under local anesthesia, and predominantly as outpatient surgery (94%).
- Patient satisfaction with ELDC was high (90%).
Conclusions:
- Endonasal laser dacryocystorhinostomy with holmium:YAG laser is a viable and effective treatment for nasolacrimal obstruction.
- The laser technique offers advantages in terms of reduced invasiveness, shorter procedure time, and outpatient suitability.
- ELDC provides comparable results to conventional DCR with improved patient experience.